Structural mechanisms of costimulation

Nature Immunology

Volumn 3, Issue 5, 2002, Pages 427-434

  Schwartz, Jean Claude D ^a   Zhang, Xuewu ^a   Nathenson, Stanley G ^a   Almo, Steven C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CELL SURFACE RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LIGAND;

ANIMAL CELL; BINDING AFFINITY; CONTROLLED STUDY; DIMERIZATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; HUMANS; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0036094253     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni0502-427     Document Type: Review

References (73)

1. Protein tyrosine kinase structure and function
2. Erythropoietin receptor activation by a ligand-induced conformation change
3. Quaternary structure of the insulin-insulin receptor complex
4. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex
5. Crystal structure of the B7-I/CTLA-4 complex that inhibits human immune responses
6. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity
7. Crystal structure of an Eph receptor-ephrin complex
8. CD28/B7 system of T cell costimulation
9. Development of lupus-like autoimmune diseases by disruption of the PD-I gene encoding an ITIM motif-carrying immunoreceptor
10. Autoimmune dilated cardiomyopathy in PD-I receptor-deficient mice
11. CTLA-4 regulates induction of anergy in vivo
12. Studies using antigen-presenting cells lacking expression of both B7-I (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production
13. + T cells
14. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
15. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFα
16. T-cell co-stimulation through B7RP-1 and ICOS
17. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death
18. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
19. PD-L2 is a second ligand for PD-1 and inhibits T cell activation
20. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
21. The immunological synapse
22. T cell receptor signaling precedes immunological synapse formation
23. Immunology. The immunological synapse-A multitasking system
24. CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy
25. A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes
26. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
27. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
28. Structure and dimerization of a soluble form of B7-1
29. Expression, refolding, purification, molecular characterization, crystallization and preliminary x-ray analysis of the receptor binding domain of human B7-2
30. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28
31. The immunoglobulin superfamily-domains for cell surface recognition
32. Structure of murine CTLA-4 and its role in modulating T cell responsiveness
33. Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86)
34. Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution
35. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex
36. Structure of an HIV gp 120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
37. Complementarity determining region I (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1
38. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28
39. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2)
40. Characterization of CTLA-4 structure and expression on human T cells
41. Transmembrane signaling through CD80 (B7-1) induces growth arrest and cell spreading of human B lymphocytes accompanied by protein tyrosine phosphorylation
42. CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells
43. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphomas
44. Structural basis of cell-cell adhesion by cadherins
45. A receptor/cytoskeletal movement triggered by costimulation during T cell activation
46. The immunological synapse and CD28-CD80 interactions
47. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2
48. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors
49. Dependence of T cell antigen recognition on the dimensions of an accessory receptor-ligand complex
50. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding
51. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule
52. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor
53. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
54. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
55. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation
56. Physiological regulation of the immunological synapse by agrin
57. Tumor necrosis factor receptor and Fas signaling mechanisms
58. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
59. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor
60. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation
61. Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5
62. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation
63. Signalling through the high-affinity IgE receptor FcεRI
64. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
65. Dali: A network tool for protein structure comparison
66. Protein multiple sequence alignment and flexible pattern matching
67. SETOR: Hardware-lighted three-dimensional solid model representation of macromolecules
68. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells
69. Janus kinase 2 is associated with a box I-like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule-4
70. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A
71. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4
72. Molecular basis of T cell inactivation by CTLA-4
73. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein